Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease : experience from the Phase 3 ATTRACT study
View/ Open
Date
2019Author
Type
Subject
In
American journal of medical genetics. Part A. Hoboken, N.J. : Wiley-Blackwell. Vol. 179A (2019), p. 1069–1073
Source
Foreign
Collections
-
Journal Articles (42957)Health Sciences (11671)
-
Journal Articles (42957)Biological Sciences (3370)
This item is licensed under a Creative Commons License
